Single Dose Pharmacodynamic and Pharmacokinetic Study of DG3173
Clinical trial NCT02217826 · COMPLETED
Trial details
- NCT number
- NCT02217826
- Sponsor
- Aspireo Pharmaceuticals Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Primary completion
- 2014-04-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.